Cambridge Investment Research Advisors’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-8,682
| Closed | -$393K | – | 3431 |
|
|
2024
Q2 | $393K | Sell |
8,682
-500
| -5% | -$22.6K | ﹤0.01% | 2482 |
|
|
2024
Q1 | $360K | Buy |
+9,182
| New | +$360K | ﹤0.01% | 2557 |
|
|
2023
Q1 | – | Sell |
-2,225
| Closed | -$7K | – | 3172 |
|
|
2022
Q4 | $7K | Sell |
2,225
-236
| -10% | -$742 | ﹤0.01% | 3082 |
|
|
2022
Q3 | $12K | Buy |
2,461
+14
| +0.6% | +$68 | ﹤0.01% | 3018 |
|
|
2022
Q2 | $19K | Sell |
2,447
-34
| -1% | -$264 | ﹤0.01% | 3001 |
|
|
2022
Q1 | $40K | Sell |
2,481
-1,383
| -36% | -$22.3K | ﹤0.01% | 3092 |
|
|
2021
Q4 | $71K | Buy |
3,864
+833
| +27% | +$15.3K | ﹤0.01% | 3067 |
|
|
2021
Q3 | $93K | Buy |
3,031
+6
| +0.2% | +$184 | ﹤0.01% | 2963 |
|
|
2021
Q2 | $166K | Buy |
3,025
+35
| +1% | +$1.92K | ﹤0.01% | 2881 |
|
|
2021
Q1 | $177K | Sell |
2,990
-312
| -9% | -$18.5K | ﹤0.01% | 2665 |
|
|
2020
Q4 | $124K | Sell |
3,302
-643
| -16% | -$24.1K | ﹤0.01% | 2569 |
|
|
2020
Q3 | $213K | Buy |
3,945
+1,748
| +80% | +$94.4K | ﹤0.01% | 2194 |
|
|
2020
Q2 | $553K | Buy |
2,197
+594
| +37% | +$150K | ﹤0.01% | 1495 |
|
|
2020
Q1 | $252K | Sell |
1,603
-22
| -1% | -$3.46K | ﹤0.01% | 1778 |
|
|
2019
Q4 | $266K | Sell |
1,625
-26
| -2% | -$4.26K | ﹤0.01% | 1986 |
|
|
2019
Q3 | $241K | Buy |
1,651
+35
| +2% | +$5.11K | ﹤0.01% | 1984 |
|
|
2019
Q2 | $336K | Buy |
1,616
+7
| +0.4% | +$1.46K | ﹤0.01% | 1680 |
|
|
2019
Q1 | $336K | Buy |
1,609
+25
| +2% | +$5.22K | ﹤0.01% | 1740 |
|
|
2018
Q4 | $278K | Buy |
1,584
+388
| +32% | +$68.1K | ﹤0.01% | 1709 |
|
|
2018
Q3 | $271K | Buy |
1,196
+413
| +53% | +$93.6K | ﹤0.01% | 1861 |
|
|
2018
Q2 | $119K | Sell |
783
-415
| -35% | -$63.1K | ﹤0.01% | 2091 |
|
|
2018
Q1 | $219K | Buy |
1,198
+301
| +34% | +$55K | ﹤0.01% | 1907 |
|
|
2017
Q4 | $191K | Buy |
897
+10
| +1% | +$2.13K | ﹤0.01% | 1943 |
|
|
2017
Q3 | $190K | Buy |
+887
| New | +$190K | ﹤0.01% | 1839 |
|